Published online Jul 7, 2020. doi: 10.3748/wjg.v26.i25.3517
Peer-review started: March 3, 2020
First decision: April 25, 2020
Revised: April 27, 2020
Accepted: June 10, 2020
Article in press: June 10, 2020
Published online: July 7, 2020
Core tip: Totally implantable access port is a fully implantable drug delivery system that is implanted subcutaneously and can be retained for a long time. Advantages of ports include a simple nursing process, low risk of infection and embolism, and high patient comfort. Currently no practice guideline is available. In order to reduce port-related complications, the Chinese Research Hospital Association Digestive Tumor Committee, the Chinese Association of Upper Gastrointestinal Surgeons, the Chinese Gastric Cancer Association, and the Gastrointestinal Surgical Group of Chinese Surgical Society Affiliated to Chinese Medical Association have, for the first time, organized multidisciplinary expert discussions at the General Hospital of the People’s Liberation Army and nation-wide expert letter reviews and on-site seminars, and formulated the present expert consensus of the operation guidelines.